Skip to content

Drug interactions

Nirmatrelvir / ritonavir + Sofosbuvir-velpatasvir

Severity: Minor

Nirmatrelvir / ritonavir and Sofosbuvir-velpatasvir: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Ritonavir is a strong CYP3A and P-gp inhibitor and also affects other enzymes, which could raise exposure to velpatasvir and sofosbuvir. Short courses generally carry limited risk, but exposure changes are possible.

What this interaction means in plain words

Nirmatrelvir / ritonavir and Sofosbuvir-velpatasvir have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Evidence level: Low

Why it happens

Ritonavir inhibition of CYP3A and P-gp may raise velpatasvir and sofosbuvir exposure.

What to do

Coadministration over the 5-day course is usually acceptable; monitor for antiviral adverse effects.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Nirmatrelvir / ritonavir and Sofosbuvir-velpatasvir, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Nirmatrelvir / ritonavir with Sofosbuvir-velpatasvir?

MediHelp rates the interaction as minor. Nirmatrelvir / ritonavir and Sofosbuvir-velpatasvir have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Ritonavir is a strong CYP3A and P-gp inhibitor and also affects other enzymes, which could raise exposure to velpatasvir and sofosbuvir. Short courses generally carry limited risk, but exposure changes are possible.

How serious is the interaction between Nirmatrelvir / ritonavir and Sofosbuvir-velpatasvir?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Coadministration over the 5-day course is usually acceptable; monitor for antiviral adverse effects.

What other medicines interact with Sofosbuvir-velpatasvir?

MediHelp also lists interactions of Sofosbuvir-velpatasvir with, for example, Rifampin, Rifapentine, St john's wort. The full list is on the Sofosbuvir-velpatasvir page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in